Reported 8 months ago
The Taiwan Stock Exchange will host a biotech theme forum on June 27, featuring discussions on 'Revolutionizing Next Generation Healthcare for a Global New Perspective' and 'Leading Innovative Capital, Co-Creating Tomorrow's Blueprint.' Executives such as Sheng Baoxi, Chairman of Par Sterile Products (6472), Lu Kongming, Founder of Middle Day Biotech Group (4128) and Chairman of Diamond Biotech (6901), and Lin Chenglong, Founder of Perll Biomedical Innovation (6949), will attend. The Stock Exchange aims to leverage Taiwan's innovative startup advantages and visibility, positioning itself as the top choice for innovative technology industries in the Asia-Pacific region such as biotech, IoT, AI, and big data, facilitating companies with key core technologies and innovative capabilities to apply for listing, fostering the country's startup environment, and supporting startups in accessing capital markets.
Source: YAHOO